The following discussion and analysis of our results of operations and financial
condition for the fiscal years ended December 31, 2022 and 2021 should be read
in conjunction with our Financial Statements and the notes to those Financial
Statements that are included elsewhere in this Form 10-K and were prepared
assuming that we will continue as a going concern. Our discussion includes
forward-looking statements based upon current expectations that involve risks
and uncertainties, such as our plans, objectives, expectations and intentions.
Actual results and the timing of events could differ materially from those
anticipated in these forward-looking statements as a result of a number of
factors, including those set forth under the "Risk Factors," "Cautionary Notice
Regarding Forward-Looking Statements" and "Description of Business" sections and
elsewhere in this Form 10-K. We use words such as "anticipate," "estimate,"
"plan," "project," "continuing," "ongoing," "expect," "believe," "intend,"
"may," "will," "should," "could," "predict," and similar expressions to identify
forward-looking statements. Although we believe the expectations expressed in
these forward-looking statements are based on reasonable assumptions within the
bounds of our knowledge of our business, our actual results could differ
materially from those discussed in these statements. We undertake no obligation
to update publicly any forward-looking statements for any reason even if new
information becomes available or other events occur in the future.



In the below discussion, "we," "our," "us," the "Company" and similar terms in this report, as well as references to "UMED" and "Greenway" all refer to Greenway Technologies, Inc., and our wholly-owned subsidiary, Greenway Innovative Energy, Inc., unless the context requires otherwise.

Greenway Technologies, Inc. is engaged in the research and development of
proprietary gas-to-liquids syngas conversion systems and micro-plants that can
be scaled to meet specific gas field production requirements. The company's
patented and proprietary technologies have been realized in its first commercial
G-Reformer unit, a unique component used to convert natural gas into synthesis
gas, which when combined with a Fischer-Tropsch reactor and catalyst, produces
fuels including gasoline, diesel, jet fuel and methanol. G-Reformer units can be
deployed to process a variety of natural gas streams including pipeline gas,
associated gas, flared gas, vented gas, coal-bed methane and/or biomass gas.
When derived from any of these natural gas sources, the liquid fuels created are
incrementally cleaner than conventionally produced oil-based fuels. Greenway's
objective is to become a material direct and licensed producer of renewable GTL
synthesized diesel and jet fuels, with a near term focus on U.S. market
opportunities.



The Company believes that its proprietary G-Reformer is a major innovation in
gas reforming and GTL technology in general. Initial tests have demonstrated
that the Company's solution appears to be superior to legacy technologies which
are more costly, have a larger footprint and cannot be easily deployed at field
sites to process associated gas, stranded gas, coal-bed methane, vented gas, or
flared gas - all markets the Company seeks to service.



On April 28, 2020, the Company was issued a new U.S. Patent 10,633,594 B1 for
syngas generation for gas-to-liquid fuel conversion. The Company has several
other pending patent applications, both domestic and international, related to
various components and processes involving our proprietary GTL methods, which
when granted, will further complement our existing portfolio of issued patents
and pending patent applications.



On December 8, 2020, the Company announced an exclusive worldwide patent licensing agreement with the University of Texas at Arlington (UTA) for all patent applications currently filed with the Patent and Trademark Office relating to GWTI's natural gas reforming technologies developed under its sponsored research agreement with UTA.





-14-






On December 15, 2020, the Company announced additional information regarding
valuable outputs produced by the company's proprietary G-Reformer™ catalyst
reactor and Fischer-Tropsch (FT) technology which combine to form the
"Greer-Wright" GTL solution. Originally developed to convert natural gas into
ultra-clean synthetic fuel, recent research and development activity has shown
that the technology can also allow the extraction of high-value chemicals and
alcohols. The chemical outputs include n-Hexane, n-Heptane, n-Octane, n-Decane,
n-Dodecane, and n-Tridecane. Alcohols produced include ethanol and methanol. The
company has identified worldwide industrial demand for these outputs which will
significantly improve the economic return on investment (ROI) of GTL plants that
are based on GWTI's technology. GWTI is a development-stage company with plans
to continue its unique and patented technology.



In February 2021, the Company was issued Patent 10,907,104, the fourth patent
relating to the company's proprietary G-Reformer™ technology which allows for
the conversion of natural gas into synthesis gas. The newly issued patent
extends the methods and details of generating syngas using the apparatus
described in a previously issued patent No. 10,633,594, the company's third
patent. As described in the patent, methane, oxygen, and steam are continuously
injected into the combustion section of the apparatus to generate carbon
monoxide along with unreacted methane and steam. The carbon monoxide, unreacted
methane, and steam then enter the catalyst chamber where these components react
to generate syngas. The pressure inside the reaction vessel is controlled at no
higher than 5 psig.



Further, the Company believes its technologies and processes will allow for
multiple small-scale GTL plants to be built with substantially lower up-front
and ongoing costs resulting in more profitable results for O&G operators. In
addition, the proprietary technology based around the G-Reformer is unique in
that it also allows for transportable (mobile) GTL plants with a much smaller
footprint as compared to legacy large-scale technologies. Greenway is in
discussions with a number of oil and gas operators and other interested parties
to license and obtain joint venture or other forms of capital funding to build
its first third-party customer gas-to-liquid plant.



Mining Interest



In December 2010, UMED acquired the rights to approximately 1,440 acres of
placer mining claims located on Bureau of Land Management ("BLM") land in Mohave
County, Arizona for 5,066,000 shares of restricted Common A stock. Early
indications, from samples taken and processed, provided reason to believe that
the potential recovery value of the metals located on the 1,440 acres is
significant, but only actual mining and processing will determine the ultimate
value which may be realized from this property holding. The Company is currently
exploring strategic options to partner or sell its interest in this acreage,
while it focuses on its emerging GTL technology sales and marketing efforts.



Going Concern



We remain dependent on outside sources of funding (debt and/or equity) for
continuation of our operations. Our independent registered public accounting
firm issued a going concern qualification in their report dated April 14, 2023,
which is included with our consolidated Financial Statements and raises
substantial doubt about our ability to continue as a going concern.



                                                                         $
                               December 31,       December 31,        Increase
                                   2022               2021           (Decrease)        % Change

Net loss                       $   1,512,692     $    1,744,376     $   (231,684 )         -13.28 %   1
Net cash used in operations    $     496,654     $      791,906     $   (295,252 )         -37.28 %   2
Working capital deficit        $  10,737,576     $    9,886,820     $    850,756             8.60 %   3

Stockholders' deficit $ 10,737,576 $ 9,886,820 $ 850,756

             8.60 %   4




1 - Our net loss decreased primarily due to recording a gain on debt settlement
of $70,377 and decreases in our operating expenses of $178,027, (both general
and administrative expenses and research and development), from $1,120,901

to
$942,874.



2 - Our net cash used in operations in 2022 was less than 2021. The change was
primarily due to the recognition of a gain on debt settlement of $70,377 and an
increase in accounts payable and accrued expenses of $165,877.



3 - The increase in working capital deficit from 2021 to 2022 primarily relates
to less cash in 2022 of $35,954, higher accounts payable and accrued expenses of
$101,283, higher accounts payable and accrued expenses - related party of
$707,914.



4 - The increase from 2021 to 2022 is based upon the current year net loss.

These factors raise substantial doubt about our ability to continue as a going concern.





The Financial Statements included in our Form 10-K do not include any
adjustments relating to the recoverability and classification of recorded asset
amounts or amounts and classification of liabilities that might be necessary
should we be unable to continue in existence. Our ability to continue as a going
concern is dependent upon our ability to generate sufficient new cash flows to
meet our obligations on a timely basis, to obtain additional financing as may be
required, and/or ultimately to attain profitable operations. However, there is
no assurance that profitable operations, financing, or sufficient new cash

flows
will occur in the future.



-15-






Our ability to achieve profitability will depend upon our ability to finance,
manufacture, and market/operate GTL units. Our growth is dependent on attaining
profit from our operations and our raising additional capital either through the
sale of our Common Stock or borrowing. There is no assurance that we will be
able to raise any equity financing or sell any of our products at a profit. We
will be unable to pay our obligations in the normal course of business or
service our debt in a timely manner throughout 2023 without raising additional
debt or equity capital. There can be no assurance that we will raise additional
debt or equity capital.



We are currently evaluating strategic alternatives that include (i) raising new
equity capital and/or (ii) issuing additional debt instruments. The process is
ongoing, lengthy and has inherent costs. There can be no assurance that the
exploration of these strategic alternatives will result in any specific action
to alleviate our 12-month working capital needs or result in any other
transaction.



While we are attempting to commence operations and generate revenues, our cash
position may not be significant enough to support our daily operations.
Management intends to raise additional funds by way of an offering of our
securities. Management believes that the actions presently being taken to
further implement our business plan and generate revenues provide the
opportunity for us to continue as a going concern. While we believe in the
viability of our strategy to generate revenues and in our ability to raise
additional funds, we may not be successful. Our ability to continue as a going
concern is dependent upon our capability to further implement our business plan
and generate revenues.



Results of Operations

For Year Ended December 31, 2022 as Compared to Year Ended December 31, 2021:

We had no revenues for consolidated operations for the years ended December 31, 2022 and 2021.

We reported consolidated net losses during the years ended December 31, 2022 and 2021 of $1,512,692 and $1,744,376, respectively.

The following table summarizes consolidated operating expenses and other income and expenses for the years ended December 31, 2022 and December 31, 2021:





                                                                          $
                                December 31,       December 31,        Increase
                                    2022               2021           (Decrease)        % Change

Revenues                       $            -     $            -     $          -             0.00 %

General and administrative
expenses                       $      888,599     $      962,901     $    (74,302 )          -7.72 %   1
Research and development       $       54,275     $      158,000     $   (103,725 )         -65.65 %   2
Interest expense               $      591,963     $      588,273     $      3,690             0.63 %   3
Amortization of debt
discount                       $       48,232     $       35,202     $     13,030            37.01 %   4
Gain on debt settlement        $      (70,377 )   $            -     $    (70,377 )           0.00 %   5



Total operating expenses decreased by $178,027 from $1,120,901 in 2021 to $942,874 in 2022.





1 - The decrease was primarily due to a decrease of $59,726 in consulting fees
and a decrease of $52,507 in salaries. The Company also had increases related to
legal and professional fees of $19,358.

2 - The decrease was related to less activity in 2022 due to lack of sufficient resources and inability to pursue additional R&D related activities.

3 - The increase is based on higher outstanding debt balances throughout the year.

4 - Amortization of discounts on debt instruments that were executed at various times throughout the current period.

5 - The Company settled a legal matter in 2022.

Net Loss and Net Loss per Share





Our consolidated net loss decreased by $231,684 to $1,512,692 ($0.00) - basic
and diluted earnings share for the year ended December 31, 2022, as compared to
a net loss of $1,744,376 ($0.01), for the same period ended 2021.



The weighted-average number of shares of Common Stock used in the earnings per
share for the basic and dilutive computation was 371,601,679 for the year ended
December 31, 2022, and 342,400,231 for the year ended December 31, 2021.



-16-





Liquidity and Capital Resources





We do not currently have sufficient working capital to fund our expected future
operations. We cannot assure investors that we will be able to continue our
operations without securing additional adequate funding. We had $24,595 in cash,
total assets of $27,542, and total liabilities of $10,765,118 as of December 31,
2022. Total accumulated deficit at December 31, 2022, was ($36,278,869).



Liquidity is the ability of a company to generate adequate amounts of cash to
meet all of its financial obligations. The following table provides certain
selected balance sheet comparisons between December 31, 2022, and December

31,
2021:



                                                                         $
                               December 31,       December 31,        Increase
                                   2022               2021           (Decrease)       % Change

Cash                           $      24,595     $       60,549     $    (35,954 )        -59.38 %   1

Prepaids and other             $       2,947     $           56     $      2,891         5162.50 %   2
Total current assets           $      27,542     $       60,605     $    (33,063 )        -54.55 %   3
Total assets                   $      27,542     $       60,605     $    

(33,063 ) -54.55 % 3



Accounts payable and accrued
expenses                       $   3,317,225     $    3,215,942     $    101,283            3.15 %   4

Accounts payable and accrued expenses - related party $ 3,799,452 $ 3,091,538 $ 707,914

           22.90 %   4
Note payable                   $     672,500     $      660,000     $     12,500            1.89 %   5
Notes payable - related
parties - net                  $   2,805,774     $    2,745,264     $     60,510            2.20 %   5
Convertible note payable -
net                            $     166,667     $      166,667     $          -            0.00 %   5

Advances - related parties $ 3,500 $ 68,014 $ (64,514 ) -94.85 % 6 Total current liabilities $ 10,765,118 $ 9,947,425 $ 817,693

            8.22 %   7
Total liabilities              $  10,765,118     $    9,947,425     $    817,693            8.22 %   7



1 - Cash decreased in 2022 due to payment of accounts payable and less capital raised to sustain operations as compared to prior period.

2 - Insignificant change.

3 - See discussion regarding cash resources in #1 above.

4 - Lack of cash resources resulted in an increase in these liabilities.

5 - Increase in 2022 related to proceeds of $30,000 offset by repayments of $55,000.

6 - In 2022, there was a conversion of stockholder advances totaling $51,769 to notes payable - related parties.

7 - See discussions in 4, 5 and 6.





-17-





To increase our working capital, we have considered completing additional private stock sales and entering into new debt instruments. During the year ended December 31, 2022, we received advances of $3,500 from related parties and $30,000 in proceeds from the issuance of debt.





Cash Flows



                                                                              $
                                    December 31,       December 31,       Increase
                                        2022               2021          (Decrease)       % Change

Net cash used in operating
activities                         $      496,654     $      791,906     $  (295,252 )        -37.28 %
Net cash used in investing
activities                         $            -     $            -     $         -            0.00 %
Net cash provided by financing
activities                         $      460,700     $      850,827     $  (390,127 )        -45.85 %




Operating Activities


Our net cash used in operations in 2022 was less than 2021. The change was primarily due to the recognition of a gain on debt settlement of $70,377, an increase in accounts payable and accrued expenses of $326,660 and accounts payable and accrued expenses - related parties of $707,914.





Investing activities


Net cash used in investing activities for the year ending December 31, 2022 and 2021 was $0.





Financing Activities



In 2022, the Company had net cash provided by financing activities of $460,700, consisting of the following:

Proceeds from advances - related parties - $3,500

Proceeds from issuance of note payable - $30,000

Repayments on notes payable - $55,000

Proceeds from stock issued for cash - $482,200


Our accompanying consolidated financial statements have been prepared on a going
concern basis, which contemplates realization of assets and the satisfaction of
liabilities in the normal course of business. Our general business strategy is
to first develop our GTL technology to maintain our basic viability, while
seeking significant development capital for full commercialization.



As shown in the accompanying consolidated financial statements, we have incurred
an accumulated deficit of $36,278,869 and $34,766,177 as of December 31, 2022
and 2021, respectively.


Our ability to continue as a going concern is in doubt and dependent upon achieving a profitable level of operations and on our ability to obtain necessary financing to fund ongoing operations.





Commitments



Capital Expenditures - none



Operational Expenditures



Employment Agreements



In August 2012, we entered into an employment agreement with Raymond Wright, for
the position of president of GIE, for a term of five years with compensation of
$90,000 per year. In September 2014, Mr. Wright's employment agreement was
amended to increase his annual pay to $180,000. By its terms, Mr. Wright's
employment agreement automatically renewed on August 12, 2020, 2021, and 2022
for a successive one-year periods. During the twelve-months ended December 31,
2022, we paid and/or accrued a total of $180,000 for this calendar year under
the terms of the agreement. Mr. Wright is also the chairman of our Board of

Directors.



-18-






Effective May 10, 2018, we entered into identical employment agreements with
John Olynick, as President, and Ransom Jones, as Chief Financial Officer,
respectively. The terms and conditions of their employment agreements were
identical. John Olynick elected not to renew his employment agreement and
resigned as President on July 19, 2019. Ransom Jones, as Chief Financial
Officer, earns a salary of $120,000 per year. Mr. Jones also serves as the
Company's Secretary and Treasurer. During each year that Mr. Jones' agreement is
in effect, he is entitled to receive a bonus ("Bonus") equal to at least
Thirty-Five Thousand Dollars ($35,000) per year, such amount having been accrued
for the period ended December 31, 2022. Both Mr. Olynick and Mr. Jones received
a grant of common stock (the "Stock Grant") at the start of their employment
equal to 250,000 shares each of the Company's Common Stock, par value $.0001 per
share (the "Common Stock"), such shares vesting immediately. Mr. Jones is also
entitled to participate in the Company's benefit plans when such plans exist.
The foregoing summary of Mr. Olynick's and Mr. Jones's employment agreement is
qualified in its entirety by reference to the actual true and correct Employment
Agreements by and between Mr. Olynick, Mr. Jones and our Company, dated May 10,
2018, copies of which are filed as Exhibits 10.39 and 10.40 to this Form 10-K
and incorporated by reference herein.



Mr. Olynick elected not to renew his employment agreement and resigned as
President on July 19, 2019. Upon his resignation, we agreed to pay the balance
of his Employment Agreement then due and owing over time. Accordingly, we
accrued $110,084 for the balance of his Employment Agreement, against which we
have paid $35,000, leaving a balance remaining of $75,084 for the year ending
December 31, 2022. In addition, Mr. Olynick had previously entered into a
consulting agreement (the "Olynick Agreement") to provide general advisory
services with us on April 18, 2019, and which included terms for payment of
billable time at $40.00 per hour, plus approved expenses. The Olynick Agreement
was terminated when Mr. Olynick became President of the Company on May 10, 2018.
We have accrued $25,510 in expenses related to such prior consulting agreement
expenses. See Exhibit 10.42 incorporated by reference herein.



Effective April 1, 2019, we entered into an employment agreement with Thomas
Phillips, Vice President of Operations, for a term of 12 months with
compensation of $120,000 per year. Mr. Phillips reports to the President of GIE.
Pursuant to his employment agreement, Mr. Phillips is entitled to a no-cost
grant of common stock equal to 4,500,000 shares of the Company's Rule 144
restricted common stock, par value $.0001 per share, with such shares having
been issued in February 2020. In addition, Mr. Phillips resigned from the
Company effective December 15, 2020. The foregoing summary of the Mr. Phillips's
employment agreement is qualified in its entirety by reference to the actual
true and correct Employment Agreement by and between Thomas Phillips and our
Company, dated April 1, 2019, a copy of which is filed as Exhibit 10.53 to this
Form 10-K and incorporated by reference herein.



Effective April 1, 2019, we entered into an employment agreement with Ryan
Turner for a term of twelve (12) months with compensation of $80,000 per year,
to manage our business development and investor relations. Mr. Turner reports to
the President of Greenway Technologies and is entitled to a no-cost grant of
common stock equal to 2,500,000 shares of the Company's Rule 144 restricted
common stock, par value $.0001 per share, valued at $.06 per share, or $150,000,
which we expensed as of the effective date of the agreement. Mr. Turner's
employment was terminated on September 7, 2021. The foregoing summary of the Mr.
Turner's employment agreement is qualified in its entirety by its reference to
the actual true and correct Employment Agreement by and between Ryan Turner and
our Company, dated April 1, 2019, a copy of which is filed as Exhibit 10.58 to
this Form 10-K and incorporated by reference herein.



Consulting Agreements



On September 7, 2018, Wildcat, a company controlled by Shareholder Marshall
Gleason, filed suit against us alleging claims arising from the Gleason
Agreement, seeking to recover monetary damages, interest, court costs, and
attorney's fees. In a separate lawsuit, Wildcat filed suit claiming that the
Company breached that certain Promissory Note dated on or about November 13,
2017, entered into between Wildcat as lender and Greenway as borrower, and as a
result Wildcat initiated an action in County Court at Law No. 2 of Tarrant
County, Texas, Cause No. 2018-006416-2. On March 6, 2019, we entered into a Rule
11 Agreement with Gleason settling both disputes, a copy of which is filed as
Exhibit 10.52 to this Form 10-K and incorporated by reference. Pursuant to the
Rule 11 Agreement, the parties agreed to abate both cases until the earlier of a
default of the performance of the Rule 11 Agreement or October 30, 2019,
whichever be sooner. The Rule 11 Agreement provided that if we timely performed
through October 15, 2019, the parties would file a joint motion for dismissal
and present agreed orders of dismissal with prejudice for both lawsuits. The
Company performed in all regards under the Rule 11 Agreement, however Gleason
refused to sign the Wildcat Settlement Agreement at the point of the Company's
having performed its obligations. The parties' respective counsels then mutually
agreed to extend the original October 30, 2019 settlement date until at least
the end of the year while the parties waited for Gleason's signature. Gleason
signed the Compromise Settlement and Release Agreement on February 4, 2020, and
all litigation was dismissed by the Court on February 25, 2020. A copy of the
Dismissal is incorporated by reference as Exhibit 10.59.



-19-






Paul Alfano, a director and greater than five percent (5%) shareholder entered
into a consulting agreement with us on April 19, 2018 via Alfano Consulting
Services (the "Alfano Agreement"), to provide board and senior management
advice, including but not limited to corporate strategy, SEC regulatory
adherence, sales and marketing strategies, document and presentation preparation
and fund-raising support. Terms included payment of billable time at $40.00 per
hour, plus approved expenses, retroactive to January 1, 2017. A copy is
available by Exhibit 10.44 incorporated by reference herein. The Alfano
Agreement was terminated when Mr. Alfano became a director on June 26, 2019. The
Company has accrued Consulting Fees and Expenses of $120,988 for all prior
periods through the year ending December 31, 2021. During 2022, Mr. Alfano and
the Company mutually agreed to issues Company shares to Mr. Alfano in full
satisfaction of the $120,988 Consulting Fees and Expenses that were accrued

as
of December 31, 2021.



On October 19, 2020, the Company entered into a management consulting services
agreement with Dean Goekel (the "Goekel Agreement" via "Analytical
Professionals"), to manage engineering and vendor relationships, assist in
defining the design and cost of certain capital equipment and to manage the
direction of research, development and other related engineering activities. Mr.
Goekel will also support the Company's ongoing business operations, including
assistance in commercialization and market implementation, strategic planning
and other services. The agreed upon start date under the agreement is July 1,
2020 and the minimum engagement term was for six (6) months. After the initial
term the agreement automatically renews for subsequent six (6) month terms
unless the Company or Mr. Goekel terminates the agreement. Under the agreement,
in exchange for Mr. Goekel's services he will receive a minimum monthly fee of
$10,000 per month in deferred compensation until such time that adequate funds
are available for payment. As of December 31, 2022, we have accrued $300,000 in
compensation expense related to this agreement. Additionally, under the
agreement Mr. Goekel was issued stock warrants for 3,000,000 shares at a strike
price of $0.03 per share effective July 1, 2020 and expiring on June 30, 2022.
The Company recognized valued and recognized compensation expense related to
these warrants of $25,137 for the year ended December 31, 2020. Mr. Goekel did
not exercise any of the stock warrant prior to June 30, 2022 and the warrants
expired unexercised. After meeting certain deliverables set forth in the
agreement, Mr. Goekel will be issued stock warrants for 1,000,000 shares at a
strike price that is an average of the stock price for the 90 days that the
deliverables have been met. No such deliverables have been met to date, and
currently management does not believe these 1,000,000 warrants will be earned by
the service provider.



Other



Pursuant to the GIE Acquisition Agreement in August 2012, we agreed to: (i)
issue an additional 7,500,000 shares of Common Stock when the first portable GTL
unit is built and becomes operational, and is capable of producing 2,000 barrels
of diesel or jet fuel per day, and (ii) pay a 2% royalty on all gross production
sales on each unit placed in production, or one percent (1%) each to the
founders and previous owners of GIE. On February 6, 2018, and in connection with
a settlement agreement dated April 5, 2018, by and between the Greer Family
Trust and us, which is the successor in interest one of the founders and prior
owners of GIE, F. Conrad Greer ("Greer"), (the "Trust", and such settlement
agreement the "Trust Settlement Agreement"), we issued 3,000,000 shares of
Common Stock and a convertible promissory note for $150,000 to the Trust in
exchange for: (i) a termination of the Trust's right to receive 3,750,000 shares
of Common Stock in the future and 1% of the royalties owed to the Trust under
the GIE Acquisition Agreement; (ii) the termination of Greer's then current
employment agreement with GIE; and (iii) the Trust's waiver of any future claims
against us for any reason. A copy of the Trust Settlement Agreement and related
promissory note dated April 5, 2018, by us in favor of the Trust is filed as
Exhibit 10.36 to this Form 10-K and incorporated by reference herein.



As a result of the transactions consummated by the Trust Settlement Agreement,
we are committed to issue a reduced number of 3,750,000 shares of Common Stock
and 1% of the royalties due on production of our GTL operational units to Ray
Wright, the other founder and prior owner of GIE, pursuant to the GIE
Acquisition Agreement.



Mining Leases



For 2022, our annual lease maintenance fees due to Bureau of Land Management
("BLM") for the Arizona, were $16,200. There is no actual lease agreement with
the BLM, but we file an annual maintenance fee form and pay fees to the BLM to
hold our claims. The next payment will be due on August 31, 2023.



-20-






Financing



Related parties



Financing to date has been provided by loans, advances from Shareholders and
Directors and issuances of our Common Stock in various private placements to
accredited investors, related parties and institutions.



For the year ended December 31, 2022 there was no related party financing. However, $51,769 in advances were converted to a related party note for Kevin Jones.

For the year ended December 31, 2021, we received $429,247 in related party loans from Mabert, acting as agent for various lenders to the Company.


As of December 31, 2021, we received $68,014 in cash and payment advances, net
of repayments, from our director, Kevin Jones, a greater than 5% shareholder
which has been accrued as "Advances - related parties" for the period.



Third-party financing



On various dates throughout the year ended December 31, 2022, the Company issued
20,667,999 shares of Rule 144 restricted Common Stock, par value $0.0001 per
share pursuant to a private placement sale to various accredited investors, for
$482,200 ($0.02 - $0.03/share).



On December 23, 2021, the Company 333,333 shares of Rule 144 restricted Common
Stock, par value $.0001 per share pursuant to a private placement sale to one
(1) accredited investor, for $10,000, or $0.03 per share.



On December 22, 2021, the Company issued 1,500,000 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
two (2) accredited investors, for $45,000, or $0.03 per share.



On December 20, 2021, the Company issued 1,000,000 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
one (1) accredited investor, for $30,000, or $0.03 per share.



On December 2, 2021, the Company issued 166,667 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
one (1) accredited investor, for $5,000, or $0.03 per share.



On November 29, 2021, the Company issued 1,000,000 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
one (1) accredited investor, for $30,000, or $0.03 per share.



On November 24, 2021, the Company 166,667 shares of Rule 144 restricted Common
Stock, par value $.0001 per share pursuant to a private placement sale to one
(1) accredited investor, for $5,000, or $0.03 per share.



On November 23, 2021, the Company 333,333 shares of Rule 144 restricted Common
Stock, par value $.0001 per share pursuant to a private placement sale to one
(1) accredited investor, for $10,000, or $0.03 per share.



On November 18, 2021, the Company issued 1,666,667 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
one (1) accredited investor, for $50,000, or $0.03 per share.



On November 3, 2021, the Company issued 1,000,000 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
one (1) accredited investor, for $30,000, or $0.03 per share.



On November 1, 2021, the Company issued 666,667 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
one (1) accredited investor, for $20,000, or $0.03 per share.



On October 8, 2021, the Company issued 625,000 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
one (1) accredited investor, for $25,000, or $0.04 per share.



On September 7, 2021, the Company issued 62,500 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
one (1) accredited investor, for $2,500, or $0.04 per share.



-21-






On September 3, 2021, the Company issued 125,000 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
one (1) accredited investor, for $5,000, or $0.04 per share.



On August 31, 2021, the Company issued 600,000 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
one (1) accredited investor, for $30,000, or $0.05 per share.



On August 30, 2021, the Company issued 200,000 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
one (1) accredited investor, for $10,000, or $0.05 per share.



On August 27, 2021, the Company issued 300,000 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
three (3) accredited investors, for $15,000, or $0.05 per share.



On August 13, 2021, the Company issued 400,000 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
one (1) accredited investor, for $20,000, or $0.05 per share.



On August 10, 2021, the Company issued 800,000 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
two (2) accredited investors, for $40,000, or $0.05 per share.



On August 9, 2021, the Company issued 100,000 shares of Rule 144 restricted Common Stock, par value $.0001 per share pursuant to a private placement sale to one (1) accredited investor, for $5,000, or $0.05 per share.

On August 5, 2021, the Company issued 400,000 shares of Rule 144 restricted Common Stock, par value $.0001 per share pursuant to a private placement sale to two (2) accredited investors, for $20,000, or $0.05 per share.

On August 3, 2021, the Company issued 500,000 shares of Rule 144 restricted Common Stock, par value $.0001 per share pursuant to a private placement sale to one (1) accredited investor, for $25,000, or $0.05 per share.

On August 2, 2021, the Company issued 200,000 shares of Rule 144 restricted Common Stock, par value $.0001 per share pursuant to a private placement sale to one (1) accredited investor, for $10,000, or $0.05 per share.


On June 22, 2021, the Company issued 382,500 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
an accredited investor, in lieu of cash payment for consulting fees of $11,475,
or $0.03 per share.


On June 3, 2021, the Company issued 2,000,000 shares of Rule 144 restricted Common Stock, par value $.0001 per share pursuant to a private placement sale to three (3) accredited investors, for $100,000, or $0.05 per share.





On May 7, 2021, the Company issued 100,000 shares of Rule 144 restricted Common
Stock, par value $.0001 per share pursuant to a private placement sale to an
accredited investor, in lieu of cash payment for consulting fees of $3,000,

or
$0.03 per share.



On May 6, 2021, the Company issued 166,667 shares of Rule 144 restricted Common
Stock, par value $.0001 per share pursuant to a private placement sale to an
accredited investor, for $5,000, or $0.03 per share.



On May 6, 2021, the Company issued 2,000,000 shares of Rule 144 restricted Common Stock, par value $.0001 per share pursuant to a private placement sale to an accredited investor, for $50,000, or $0.025 per share.





On May 6, 2021, the Company issued 600,000 shares of Rule 144 restricted Common
Stock, par value $.0001 per share pursuant to a private placement sale to an
accredited investor, for $18,000, or $0.03 per share.



On March 18, 2021, the Company issued 1,200,000 shares of Rule 144 restricted
Common Stock, par value $.0001 per share pursuant to a private placement sale to
an accredited investor, for $36,000, or $0.03 per share.



-22-






Seasonality


We do not anticipate that our business will be affected by seasonal factors.





Impact of Inflation



While we are subject to general inflationary trends, including for basic
manufacturing production materials, our management believes that inflation in
and of itself does not have a material effect on our operating results. However,
inflation may become a factor in the future. However, the COVID-19 virus and its
current extraordinary impact on the world economy has reduced oil consumption
globally, decreasing crude oil prices, to levels not seen since the early
1980's. The economics of GTL conversion rely in part on the arbitrage between
oil and natural gas prices, with economic models for many producers, including
our own models, using a range of $30-60/bbl (for WTI or Brent Crude as listed
daily on the Nymex and ICE commodities exchanges) to determine relative
profitability of their GTL operations. While the COVID-19 virus may run its
human course in the near term, we believe (as many others in the U.S. government
and media believe), that the economic impacts will be long lasting and for all
practical matters, remain largely unknown at this time.



Off-Balance Sheet Arrangements





During the year ended December 2019, we entered into a revenue interest research
and development venture with Mabert and an employee, Tom Phillips, OPMGE.
However, based on events of default in their agreement with the Company, Mabert
no longer has any formal arrangements with OPMGE or Tom Phillips. Since
inception of this arrangement, we have advanced a total of $412,885 to OPMGE.
Given the uncertainty of the collectability of this receivable, the Company has
fully reserved for this amount as of December 31, 2022 and 2021, respectively.



Critical Accounting Policies and Estimates


Our Financial Statements and accompanying notes are prepared in accordance with
generally accepted accounting principles in the United States ("GAAP").
Preparing our Financial Statements requires management to make estimates and
assumptions that impact the reported amounts of assets, liabilities, revenue,
and expenses. These estimates and assumptions are affected by management's
application of accounting policies. Critical accounting policies include revenue
recognition and impairment of long-lived assets.



-23-






We evaluate our long-lived assets for financial impairment on a regular basis in
accordance with Statement of Financial Accounting Standards No. 144, "Accounting
for the Impairment or Disposal of Long-Lived Assets," which evaluates the
recoverability of long-lived assets not held for sale by measuring the carrying
amount of the assets against the estimated discounted future cash flows
associated with them. At the time such evaluations indicate that the future
discounted cash flows of certain long-lived assets are not sufficient to recover
the carrying value of such assets, the assets are adjusted to their fair values.



We believe that the critical accounting policies discussed below affect our more
significant judgments and estimates used in the preparation of our financial
statements.



Use of Estimates



Preparing financial statements in conformity with U.S. GAAP requires management
to make estimates and assumptions that affect the reported amounts of assets and
liabilities and the disclosure of contingent assets and liabilities at the date
of the financial statements and revenues and expenses during the reported
period. Actual results could differ from those estimates, and those estimates
may be material.



Changes in estimates are recorded in the period in which they become known. The
Company bases its estimates on historical experience and other assumptions,
which include both quantitative and qualitative assessments that it believes to
be reasonable under the circumstances.



Significant estimates during the years ended December 31, 2022 and 2021, respectively, include valuation of stock-based compensation, uncertain tax positions, and the valuation allowance on deferred tax assets.

Equity Method Investment



On August 29, 2019, the Company entered into a Material Definitive Agreement
related to the formation of OPMGE. The Company contributed a limited license to
use its proprietary and patented GTL technology for no actual cost basis in
exchange for 42.86% (300 of 700 currently owned member units) revenue interest
in OPMGE, expected to be later reduced to a 30% interest upon the completion of
certain expected third-party investments for the remaining 300 of 1,000 member
units available. However, Greenway never transferred the G-Reformer to OPMGE, as
required by the LIMITED LIABILITY COMPANY AGREEMENT OF OPM GREEN ENERGY, LLC.
Accordingly, it defaulted on its obligation under the agreement. Since the
Wharton Plant is owned by Mabert, OPMGE was no longer a viable entity as of
December 31, 2022 and 2021, respectively.



-24-





As of December 31, 2022 and 2021, respectively, there were no assets within OPMGE. Accordingly, the Company's receivable with this entity is fully reserved for as of December 31, 2022 and 2021.

Cash and Cash Equivalents and Concentration of Credit Risk





For purposes of the statements of cash flows, the Company considers all highly
liquid instruments with a maturity of three months or less at the purchase date
and money market accounts to be cash equivalents.



At December 31, 2022 and 2021, respectively, the Company did not have any cash equivalents.





The Company is exposed to credit risk on its cash and cash equivalents in the
event of default by the financial institutions to the extent account balances
exceed the amount insured by the FDIC, which is $250,000. At December 31, 2022
and 2021, respectively, the Company did not have any cash in excess of the

insured FDIC limit.



Use of Estimates



The preparation of our Financial Statements in conformity with GAAP requires
management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at
the date of our Financial Statements and the reported amount of revenue and
expenses during the reported period. Actual results could differ materially

from
the estimates.



Income Taxes



The Company accounts for income tax using the asset and liability method
prescribed by ASC 740, "Income Taxes". Under this method, deferred tax assets
and liabilities are determined based on the difference between the financial
reporting and tax bases of assets and liabilities using enacted tax rates that
will be in effect in the year in which the differences are expected to reverse.
The Company records a valuation allowance to offset deferred tax assets if based
on the weight of available evidence, it is more-likely-than-not that some
portion, or all, of the deferred tax assets will not be realized. The effect on
deferred taxes of a change in tax rates is recognized as income or loss in the
period that includes the enactment date.



The Company follows the accounting guidance for uncertainty in income taxes
using the provisions of ASC 740 "Income Taxes". Using that guidance, tax
positions initially need to be recognized in the financial statements when it is
more likely than not the position will be sustained upon examination by the tax
authorities. As of December 31, 2022 and December 31, 2021, respectively, the
Company had no uncertain tax positions that qualify for either recognition or
disclosure in the financial statements.



The Company recognizes interest and penalties related to uncertain income tax
positions in other expense. No interest and penalties related to uncertain
income tax positions were recorded during the years ended December 31, 2022

and
2021, respectively.



Research and Development


The Company accounts for research and development costs in accordance with ASC subtopic 730-10, Research and Development ("ASC 730-10").





Under ASC 730-10, all research and development costs must be charged to expense
as incurred. Accordingly, internal research and development costs are expensed
as incurred. Third-party research and development costs are expensed when the
contracted work has been performed or as milestone results have been achieved as
defined under the applicable agreement. Company-sponsored research and
development costs related to both present and future products are expensed

in
the period incurred.



-25-





The Company incurred research and development expenses of $54,275 and $158,000 for the years ended December 31, 2022 and 2021, respectively.





Stock-Based Compensation



The Company accounts for our stock-based compensation under ASC 718
"Compensation - Stock Compensation" using the fair value-based method. Under
this method, compensation cost is measured at the grant date based on the value
of the award and is recognized over the service period, which is usually the
vesting period. This guidance establishes standards for the accounting for
transactions in which an entity exchanges it equity instruments for goods or
services. It also addresses transactions in which an entity incurs liabilities
in exchange for goods or services that are based on the fair value of the
entity's equity instruments or that may be settled by the issuance of those
equity instruments.



The Company uses the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options.

The fair value of stock-based compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.





When determining fair value, the Company considers the following assumptions in
the Black-Scholes model:



? Exercise price,
? Expected dividends,
? Expected volatility,
? Risk-free interest rate; and
? Expected life of option




-26-





Basic and Diluted Earnings (Loss) per Share





Pursuant to ASC 260-10-45, basic loss per common share is computed by dividing
net loss by the weighted average number of shares of common stock outstanding
for the periods presented. Diluted loss per share is computed by dividing net
loss by the weighted average number of shares of common stock, common stock
equivalents and potentially dilutive securities outstanding during the period.
Potentially dilutive common shares may consist of common stock issuable for
stock options and warrants (using the treasury stock method), convertible notes
and common stock issuable. These common stock equivalents may be dilutive in the
future.



At December 31, 2022 and 2021, respectively, the Company had the following
common stock equivalents outstanding, which are potentially dilutive equity
securities:



                    December 31, 2022       December 31, 2021

Convertible debt             3,689,400               2,083,338
        Warrants                     -               3,000,000
                             3,689,400               5,083,338




Recent Accounting Standards



Changes to accounting principles are established by the Financial Accounting
Standards Board in the form of Accounting Standards Updates ("ASU's") to the
FASB's Codification. We consider the applicability and impact of all ASU's on
our consolidated financial position, results of operations, stockholders'
deficit, cash flows, or presentation thereof. Management has evaluated all
recent accounting pronouncements as issued by the FASB in the form of Accounting
Standards Updates ("ASU") through the date these financial statements were
available to be issued and found no recent accounting pronouncements issued, but
not yet effective accounting pronouncements, when adopted, will have a material
impact on the financial statements of the Company.



Subsequent Events



From January 1, 2023 through April 14, 2023, the Company issued 10,333,333
shares of common stock comprised of: 8,333,333 shares of Rule 144 restricted
Common Stock issued in a private placement to three accredited investors at
$0.015 - $0.020 per share $160,000 and 2,000,000 shares to our Chief Financial
Officer for services rendered, having a fair value of $20,000 ($0.01/share),
based upon the quoted closing trading price.



-27-

© Edgar Online, source Glimpses